Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 4Completed 3Unknown 2Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 4354Neoplasms 3055Prostatic Neoplasms 1904Colorectal Neoplasms 1738Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Multiple Myeloma 951Leukemia, Myeloid, Acute 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 740Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

Propranolol 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Hemangioma, Cavernous, Central Nervous System × Clear all
NCT02603328 2025-08-22

AT CASH EPOC

University of Chicago

Phase 1/2 Completed
80 enrolled 19 charts
CNS

Hemangioma, Cavernous, Central Nervous System

NCT03652181 2024-06-27

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

University of Chicago

Completed
123 enrolled 27 charts
CNS

Cerebral Cavernous Malformations 3, Cerebral Cavernous Malformations 2, Hemangioma, Cavernous, Hemangioma, Capillary, Hemangioma, Cavernous, Central Nervous System

NCT03589014 2022-02-25

Treat_CCM

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
71 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡